Mark Shoemaker
Impact in
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Pharmacology top 5%
- Flavonoids in Medical Research
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 2
- Natural product bioactivities and synthesis 2
- Cell death mechanisms and regulation 1
-
- Inflammatory mediators and NSAID effects 2
- Flavonoids in Medical Research 2
- Co-authors
- Isaac Cohen (7 shared papers)Michael J. Campbell (3 shared papers)Michael J. Campbell (1 shared paper)Emma Shtivelman (4 shared papers)Mary Tagliaferri (3 shared papers)Corina Marx (3 shared papers)Christopher C. Benz (2 shared papers)Frederick L. Baehner (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Breast Cancer Research and Treatment (1 paper)PLoS ONE (1 paper)Cancer Biology & Therapy (1 paper)International Journal of Cancer (1 paper)
- Partner nations
- United StatesCanada
In The Last Decade
Mark Shoemaker
11 papers receiving 886 citations
Peers
Comparison fields: 5 of 77
- Cancer Research 286
- Pharmacology 197
- Pharmacology 64
- Complementary and alternative medicine 57
- Toxicology 23
Countries citing papers authored by Mark Shoemaker
This map shows the geographic impact of Mark Shoemaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Shoemaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Shoemaker more than expected).
Fields of papers citing papers by Mark Shoemaker
This network shows the impact of papers produced by Mark Shoemaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Shoemaker. The network helps show where Mark Shoemaker may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Shoemaker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 289 | |
| 2 | 2005 | 196 | |
| 3 | 2006 | 84 | |
| 4 | Differences in phosphate metabolite levels in drug-sensitive and -resistant human breast cancer cell lines determined by 31P magnetic resonance spectroscopy. | 1986 | 77 |
| 5 | 2009 | 74 | |
| 6 | 2004 | 72 | |
| 7 | Antiproliferative activity of Chinese medicinal herbs on breast cancer cells in vitro. | 2003 | 59 |
| 8 | 2008 | 38 | |
| 9 | 2009 | 29 | |
| 10 | 2004 | 10 | |
| 11 | 2004 | 5 |
About Mark Shoemaker
Mark Shoemaker is a scholar working on Molecular Biology, Pharmacology, Cancer Research, Surgery and Organic Chemistry, having authored 11 papers that have together received 933 indexed citations. Recurring topics across this work include Cancer, Lipids, and Metabolism (4 papers), Lipoproteins and Cardiovascular Health (3 papers), Inflammatory mediators and NSAID effects (2 papers), Flavonoids in Medical Research (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Natural product bioactivities and synthesis (2 papers), Synthesis of Tetrazole Derivatives (1 paper) and Cell death mechanisms and regulation (1 paper). The work is most often cited by research in Cancer Research (286 citations), Pharmacology (197 citations), Pharmacology (64 citations), Complementary and alternative medicine (57 citations) and Toxicology (23 citations). Mark Shoemaker has collaborated with scholars based in United States and Canada. Frequent co-authors include Isaac Cohen, Michael J. Campbell, Michael J. Campbell, Emma Shtivelman, Mary Tagliaferri, Corina Marx, Christopher C. Benz, Frederick L. Baehner, Kelly Adduci and Stephen C. Benz. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment, PLoS ONE, Cancer Biology & Therapy and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.